TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
ProPharma Group Sweden AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 65,115 | 70,396 | 72,200 |
Financial expenses | 9 | 201 | 212 |
Earnings before taxes | -3,329 | 3,506 | 10,911 |
EBITDA | -3,204 | 3,942 | 11,482 |
Total assets | 35,153 | 32,648 | 35,557 |
Current assets | 34,705 | 32,034 | 34,692 |
Current liabilities | 17,909 | 10,262 | 15,727 |
Equity capital | 15,039 | 19,377 | 16,958 |
- share capital | 67 | 73 | 74 |
Employees (average) | 65 | 57 | 62 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 42.8% | 59.4% | 47.7% |
Turnover per employee | 1,002 | 1,235 | 1,165 |
Profit as a percentage of turnover | -5.1% | 5.0% | 15.1% |
Return on assets (ROA) | -9.4% | 11.4% | 31.3% |
Current ratio | 193.8% | 312.2% | 220.6% |
Return on equity (ROE) | -22.1% | 18.1% | 64.3% |
Change turnover | 422 | -438 | 9,051 |
Change turnover % | 1% | -1% | 14% |
Chg. No. of employees | 8 | -5 | 1 |
Chg. No. of employees % | 14% | -8% | 2% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.